Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Hepatology ; 79(5): 1158-1179, 2024 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-36811413

RESUMEN

Hepatocytes work in highly structured, repetitive hepatic lobules. Blood flow across the radial axis of the lobule generates oxygen, nutrient, and hormone gradients, which result in zoned spatial variability and functional diversity. This large heterogeneity suggests that hepatocytes in different lobule zones may have distinct gene expression profiles, metabolic features, regenerative capacity, and susceptibility to damage. Here, we describe the principles of liver zonation, introduce metabolomic approaches to study the spatial heterogeneity of the liver, and highlight the possibility of exploring the spatial metabolic profile, leading to a deeper understanding of the tissue metabolic organization. Spatial metabolomics can also reveal intercellular heterogeneity and its contribution to liver disease. These approaches facilitate the global characterization of liver metabolic function with high spatial resolution along physiological and pathological time scales. This review summarizes the state of the art for spatially resolved metabolomic analysis and the challenges that hinder the achievement of metabolome coverage at the single-cell level. We also discuss several major contributions to the understanding of liver spatial metabolism and conclude with our opinion on the future developments and applications of these exciting new technologies.


Asunto(s)
Hepatopatías , Hígado , Humanos , Hígado/metabolismo , Hepatocitos/metabolismo , Hepatopatías/metabolismo , Transcriptoma , Metabolómica
2.
Clin Sci (Lond) ; 137(15): 1095-1114, 2023 08 14.
Artículo en Inglés | MEDLINE | ID: mdl-37530554

RESUMEN

The increasing prevalence of obesity brings forward its importance as a risk factor for cancer development, particularly in the gastrointestinal tract. Obesity may trigger cancer development through several mechanisms, where metabolic deregulation of adipokines can modulate multiple oncogenic molecular pathways. Leptin and adiponectin are the most well-studied adipokines, and their imbalance can trigger different tumorigenic responses. Both epidemiologic and experimental studies have associated leptin with increased cancer risk and cell responsiveness in carcinogenesis and tumor invasion. On the other hand, adiponectin is reported to elicit the opposite effect. In addition to circulating or tissue adipokine levels, adiponectin, and leptin receptors or genetic polymorphisms may also play a role in cancer development. Moreover, adiponectin and leptin modulation offer valuable therapeutic approaches. We will review the links underpinning obesity and cancer development and focus on discussing the pathophysiological roles of leptin and adiponectin.


Asunto(s)
Neoplasias Gastrointestinales , Leptina , Humanos , Leptina/metabolismo , Adiponectina/metabolismo , Obesidad/metabolismo , Adipoquinas/metabolismo , Neoplasias Gastrointestinales/etiología , Carcinogénesis
3.
Sensors (Basel) ; 20(20)2020 Oct 12.
Artículo en Inglés | MEDLINE | ID: mdl-33053633

RESUMEN

Conveyor belts are the most widespread means of transportation for large quantities of materials in the mining sector. Therefore, autonomous methods that can help human beings to perform the inspection of the belt conveyor system is a major concern for companies. In this context, we present in this work a novel and automatic visual detector that recognizes dirt buildup on the structures of conveyor belts, which is one of the tasks of the maintenance inspectors. This visual detector can be embedded as sensors in autonomous robots for the inspection activity. The proposed system involves training a convolutional neural network from RGB images. The use of the transfer learning technique, i.e., retraining consolidated networks for image classification with our collected images has shown very effective. Two different approaches for transfer learning have been analyzed. The best one presented an average accuracy of 0.8975 with an F-1 Score of 0.8773 for the dirt recognition. A field validation experiment served to evaluate the performance of the proposed system in a real time classification task.

4.
Biochim Biophys Acta ; 1857(4): 380-6, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26768116

RESUMEN

The dissimilatory adenosine 5'-phosphosulfate reductase (AprAB) is a key enzyme in the sulfate reduction pathway that catalyzes the reversible two electron reduction of adenosine 5'-phosphosulfate (APS) to sulfite and adenosine monophosphate (AMP). The physiological electron donor for AprAB is proposed to be the QmoABC membrane complex, coupling the quinone-pool to sulfate reduction. However, direct electron transfer between these two proteins has never been observed. In this work we demonstrate for the first time direct electron transfer between the Desulfovibrio desulfuricans ATCC 27774 QmoABC complex and AprAB. Cyclic voltammetry conducted with the modified Qmo electrode and AprAB in the electrolyte solution presented the Qmo electrochemical signature with two additional well-defined one electron redox processes, attributed to the AprAB FAD redox behavior. Moreover, experiments performed under catalytic conditions using the QmoABC modified electrode, with AprAB and APS in solution, show a catalytic current peak develop in the cathodic wave, attributed to substrate reduction, and which is not observed in the absence of QmoABC. Substrate dependence conducted with different electrode preparations (with and without immobilized Qmo) demonstrated that the QmoABC complex is essential for efficient electron delivery to AprAB, in order to sustain catalysis. These results confirm the role of Qmo in electron transfer to AprAB.


Asunto(s)
Proteínas del Complejo de Cadena de Transporte de Electrón/química , Oxidorreductasas actuantes sobre Donantes de Grupos Sulfuro/química , Quinonas/metabolismo , Electroquímica , Transporte de Electrón
5.
Purinergic Signal ; 13(3): 279-292, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28397110

RESUMEN

Esophageal cancer is an aggressive tumor and is the sixth leading cause of cancer death worldwide. ATP is well known to regulate cancer progression in a variety of models by different mechanisms, including P2X7R activation. This study aimed to evaluate the role of P2X7R in esophageal squamous cell carcinoma (ESCC) proliferation. Our results show that treatment with high ATP concentrations induced a decrease in cell number, cell viability, number of polyclonal colonies, and reduced migration of ESCC. The treatment with the selective P2X7R antagonist A740003 or siRNA for P2X7 reverted this effect in the KYSE450 cell line. In addition, results showed that P2X7R is highly expressed, at mRNA and protein levels, in KYSE450 lineage. Additionally, KYSE450, KYSE30, and OE21 cells express P2X3R, P2X4R, P2X5R, P2X6R, and P2X7R genes. P2X1R is expressed by KYSE30 and KYSE450, and only KYSE450 expresses the P2X2R gene. Furthermore, esophageal cancer cell line KYSE450 presented higher expression of E-NTPDases 1 and 2 and of Ecto-5'-NT/CD73 when compared to normal cells. This cell line also exhibits ATPase, ADPase, and AMPase activity, although in different levels, and the co-treatment of apyrase was able to revert the antiproliferative effects of ATP. Moreover, results showed high immunostaining for P2X7R in biopsies of patients with esophageal carcinoma, indicating the involvement of this receptor in the growth of this type of cancer. The results suggest that P2X7R may be a potential pharmacological target to treat ESCC and can lead us to further investigate the effect of this receptor in cancer cell progression.


Asunto(s)
Proliferación Celular/genética , Supervivencia Celular/genética , ARN Interferente Pequeño/genética , Receptores Purinérgicos P2X7/metabolismo , Adenosina Trifosfato/metabolismo , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/metabolismo , Línea Celular Tumoral , Neoplasias Esofágicas/genética , Neoplasias Esofágicas/metabolismo , Carcinoma de Células Escamosas de Esófago , Humanos
6.
Invest New Drugs ; 32(6): 1301-7, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25052233

RESUMEN

PURPOSE: 5-fluorouracil (5-FU) has been broadly used to treat solid tumors for more than 50 years. One of the major side effects of fluoropyrimidines therapy is oral and intestinal mucositis. Human uridine phosphorylase (hUP) inhibitors have been suggested as modulators of 5-FU toxicity. Therefore, the present study aimed to test the ability of hUP blockers in preventing mucositis induced by 5-FU. METHODS: We induced intestinal mucositis in Wistar rats with 5-FU, and the intestinal damage was evaluated in presence or absence of two hUP1 inhibitors previously characterized. We examined the loss of weight and diarrhea following the treatment, the villus integrity, uridine levels in plasma, and the neutrophil migration by MPO activity. RESULTS: We found that one of the compounds, 6-hydroxy-4-methyl-1H-pyridin-2-one-3-carbonitrile was efficient to promote intestinal mucosa protection and to inhibit the hUP1 enzyme, increasing the uridine levels in the plasma of animals. However, the loss of body weight, diarrhea intensity or neutrophil migration remained unaffected. CONCLUSION: Our results bring support to the hUP1 inhibitor strategy as a novel possibility of prevention and treatment of mucositis during the 5-FU chemotherapy, based on the approach of uridine accumulation in plasma and tissues.


Asunto(s)
Antimetabolitos Antineoplásicos/efectos adversos , Fluorouracilo/efectos adversos , Enfermedades Intestinales/tratamiento farmacológico , Mucositis/tratamiento farmacológico , Piridonas/uso terapéutico , Uridina Fosforilasa/antagonistas & inhibidores , Animales , Inhibidores Enzimáticos/uso terapéutico , Femenino , Humanos , Enfermedades Intestinales/inducido químicamente , Enfermedades Intestinales/metabolismo , Enfermedades Intestinales/patología , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/patología , Intestino Delgado/efectos de los fármacos , Intestino Delgado/metabolismo , Intestino Delgado/patología , Mucositis/inducido químicamente , Mucositis/metabolismo , Mucositis/patología , Peroxidasa/metabolismo , Ratas Wistar , Uridina/sangre
7.
J Nat Prod ; 77(10): 2190-5, 2014 Oct 24.
Artículo en Inglés | MEDLINE | ID: mdl-25302422

RESUMEN

Acute liver injury was induced in male BALB/c mice by coadministering isoniazid and rifampicin. In this work, the effects of resveratrol (1) were investigated in the hepatotoxicity caused by isoniazid-rifampicin in mice. Compound 1 was administered 30 min prior to isoniazid-rifampicin. Serum biochemical tests, liver histopathological examination, oxidative stress, myeloperoxidase activity, cytokine production (TNF-α, IL-12p70, and IL-10), and mRNA expression of SIRT1-7 and PPAR-γ/PGC1-α were evaluated. The administration of 1 significantly decreased aspartate transaminase and alanine aminotransferase levels, myeloperoxidase activity, and cytokine levels. Furthermore, 1 reverted the decrease of catalase and glutathione activities and ameliorated the histopathological alterations associated with antituberculosis drugs. Modulation of SIRT1 and PPAR-γ/PGC1-α expression is likely involved in the protective effects of 1. The results presented herein show that 1 was able to largely prevent the hepatotoxicity induced by isoniazid and rifampicin in mice, mainly by modulating SIRT1 mRNA expression.


Asunto(s)
Antituberculosos/farmacología , Isoniazida/farmacología , Rifampin/farmacología , Sirtuina 1/metabolismo , Estilbenos/farmacología , Alanina Transaminasa/sangre , Alanina Transaminasa/efectos de los fármacos , Animales , Aspartato Aminotransferasas/sangre , Aspartato Aminotransferasas/efectos de los fármacos , Enfermedad Hepática Inducida por Sustancias y Drogas , Glutatión/metabolismo , Interleucina-10/análisis , Interleucina-10/metabolismo , Hígado/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Estructura Molecular , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , PPAR gamma/efectos de los fármacos , Peroxidasa/metabolismo , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma , Resveratrol , Sirtuina 1/efectos de los fármacos , Sirtuina 1/genética , Factores de Transcripción/efectos de los fármacos , Factor de Necrosis Tumoral alfa/análisis , Factor de Necrosis Tumoral alfa/farmacología
8.
Gut Microbes ; 12(1): 1-18, 2020 11 09.
Artículo en Inglés | MEDLINE | ID: mdl-33300439

RESUMEN

New evidence shows that host-microbiota crosstalk can be modulated via endogenous miRNAs. We have previously reported that miR-21 ablation protects against liver injury in cholestasis. In this study, we investigated the role of miR-21 in modulating the gut microbiota during cholestasis and its effects in liver dysfunction. Mice lacking miR-21 had reduced liver damage and were protected against small intestinal injury as well as from gut microbiota dysbiosis when subjected to bile duct ligation surgery. The unique microbiota profile of miR-21KO mice was characterized by an increase in Lactobacillus, a key microbiome genus for gut homeostasis. Interestingly, in vitro incubation of synthetic miR-21 directly reduced Lactobacillus load. Moreover, supplementation with Lactobacillus reuteri revealed reduced liver fibrosis in acute bile duct-ligated mice, mimicking the protective effects in miR-21 knockout mice. D-lactate, a main product of Lactobacillus, regulates gut homeostasis that may link with reduced liver fibrosis. Altogether, our results demonstrate that miR-21 promotes liver dysfunction through direct modulation of the gut microbiota and highlight the potential therapeutic effects of Lactobacillus supplementation in gut and liver homeostasis.


Asunto(s)
Microbioma Gastrointestinal/genética , Lactobacillus/genética , Cirrosis Hepática/genética , Hígado/lesiones , MicroARNs/genética , Animales , Colestasis/patología , Disbiosis/genética , Disbiosis/prevención & control , Femenino , Microbioma Gastrointestinal/fisiología , Ácido Láctico/metabolismo , Hígado/patología , Cirrosis Hepática/microbiología , Cirrosis Hepática/patología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados
9.
Brain Commun ; 2(2): fcaa165, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33426525

RESUMEN

The influence of dietary factors on brain health and mental function is becoming increasingly recognized. Similarly, mounting evidence supports a role for gut microbiota in modulating central nervous system function and behaviour. Still, the molecular mechanisms responsible for the impact of diet and associated microbiome in adult neurodegeneration are still largely unclear. In this study, we aimed to investigate whether and how changes in diet-associated microbiome and its metabolites impact on adult neurogenesis. Mice were fed a high-fat, choline-deficient diet, developing obesity and several features of the metabolic syndrome, including non-alcoholic steatohepatitis. Strikingly, our results showed, for the first time, that animals fed with this specific diet display premature increased neurogenesis, possibly exhausting the available neural stem cell pool for long-term neurogenesis processes. The high-fat, choline-deficient diet further induced neuroinflammation, oxidative stress, synaptic loss and cell death in different regions of the brain. Notably, this diet-favoured gut dysbiosis in the small intestine and cecum, up-regulating metabolic pathways of short-chain fatty acids, such as propionate and butyrate and significantly increasing propionate levels in the liver. By dissecting the effect of these two specific short-chain fatty acids in vitro, we were able to show that propionate and butyrate enhance mitochondrial biogenesis and promote early neurogenic differentiation of neural stem cells through reactive oxygen species- and extracellular signal-regulated kinases 1/2-dependent mechanism. More importantly, neurogenic niches of high-fat, choline-deficient-fed mice showed increased expression of mitochondrial biogenesis markers, and decreased mitochondrial reactive oxygen species scavengers, corroborating the involvement of this mitochondrial stress-dependent pathway in mediating changes of adult neurogenesis by diet. Altogether, our results highlight a mitochondria-dependent pathway as a novel mediator of the gut microbiota-brain axis upon dietary influences.

10.
Odontol. Clín.-Cient ; 20(1): 90-93, jan.-mar. 2021. ilus
Artículo en Portugués | LILACS, BBO - odontología (Brasil) | ID: biblio-1368457

RESUMEN

Oroantral communication (OAC) is characterized by formation of direct access between the oral cavity and the maxillary sinus. This access can be lined by epithelium overtime, being called oroantral fistula (OAF). Its etiology is varied; however, it is usually associated with surgical procedures in the posterior re gion of the maxilla. Diagnosis is made through clinical and imaging evaluation. The treatment involves different surgical techniques, such as use of vestibular or palatal surgical flaps, nasal septum cartilage and, more commonly, buccal adipose body. The aim of this study was to describe therapeutic approach in a case of OAF, resulted from a dental implant complication, in a 65-year-old male patient. Fistulec tomy was performed and communication was closed by advancement buccal fat pad. The patient is in complete regression of the lesion and has no recurrences... (AU)


A comunicação oro-antral (COA) é caracterizada pela formação de acesso direto entre a cavidade bucal e o seio maxilar. Com o decorrer do tempo, esse acesso passa a ser revestido por epitélio, sendo chamado de fístula oro-antral (FOA). Sua etiologia é variada, no entanto, está geralmente associada a procedimentos cirúrgicos na região posterior de maxila. O diagnóstico é realizado através do exame clínico e imaginológico. O tratamento envolve diferentes técnicas cirúrgicas, como uso de retalhos cirúrgicos vestibulares ou palatinos, cartilagem do septo nasal e, mais comumente, o corpo adiposo da bochecha. O objetivo desse trabalho foi descrever a conduta terapêutica frente a um caso de FOA, decorrente de complicação de implante dentário, em um paciente do sexo masculino de 65 anos. Foi realizada fistulectomia e fechamento da comunicação mediante avanço da bola de Bichat. O paciente encontra-se com total regressão da lesão e sem recidivas... (AU)


Asunto(s)
Humanos , Masculino , Anciano , Colgajos Quirúrgicos , Tejido Adiposo , Fístula Oroantral , Seno Maxilar
11.
Front Microbiol ; 6: 1392, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26733949

RESUMEN

The precise interpretation of environmental sulfur isotope records requires a quantitative understanding of the biochemical controls on sulfur isotope fractionation by the principle isotope-fractionating process within the S cycle, microbial sulfate reduction (MSR). Here we provide the only direct observation of the major ((34)S/(32)S) and minor ((33)S/(32)S, (36)S/(32)S) sulfur isotope fractionations imparted by a central enzyme in the energy metabolism of sulfate reducers, dissimilatory sulfite reductase (DsrAB). Results from in vitro sulfite reduction experiments allow us to calculate the in vitro DsrAB isotope effect in (34)S/(32)S (hereafter, [Formula: see text]) to be 15.3 ± 2‰, 2σ. The accompanying minor isotope effect in (33)S, described as [Formula: see text], is calculated to be 0.5150 ± 0.0012, 2σ. These observations facilitate a rigorous evaluation of the isotopic fractionation associated with the dissimilatory MSR pathway, as well as of the environmental variables that govern the overall magnitude of fractionation by natural communities of sulfate reducers. The isotope effect induced by DsrAB upon sulfite reduction is a factor of 0.3-0.6 times prior indirect estimates, which have ranged from 25 to 53‰ in (34)εDsrAB. The minor isotope fractionation observed from DsrAB is consistent with a kinetic or equilibrium effect. Our in vitro constraints on the magnitude of [Formula: see text] is similar to the median value of experimental observations compiled from all known published work, where (34)ε r-p = 16.1‰ (r-p indicates reactant vs. product, n = 648). This value closely matches those of MSR operating at high sulfate reduction rates in both laboratory chemostat experiments ([Formula: see text] 17.3 ± 1.5‰, 2σ) and in modern marine sediments ([Formula: see text] 17.3 ± 3.8‰). Targeting the direct isotopic consequences of a specific enzymatic processes is a fundamental step toward a biochemical foundation for reinterpreting the biogeochemical and geobiological sulfur isotope records in modern and ancient environments.

12.
Science ; 350(6267): 1541-5, 2015 Dec 18.
Artículo en Inglés | MEDLINE | ID: mdl-26680199

RESUMEN

Microbial sulfate reduction has governed Earth's biogeochemical sulfur cycle for at least 2.5 billion years. However, the enzymatic mechanisms behind this pathway are incompletely understood, particularly for the reduction of sulfite-a key intermediate in the pathway. This critical reaction is performed by DsrAB, a widespread enzyme also involved in other dissimilatory sulfur metabolisms. Using in vitro assays with an archaeal DsrAB, supported with genetic experiments in a bacterial system, we show that the product of sulfite reduction by DsrAB is a protein-based trisulfide, in which a sulfite-derived sulfur is bridging two conserved cysteines of DsrC. Physiological studies also reveal that sulfate reduction rates are determined by cellular levels of DsrC. Dissimilatory sulfate reduction couples the four-electron reduction of the DsrC trisulfide to energy conservation.


Asunto(s)
Proteínas Arqueales/metabolismo , Archaeoglobus fulgidus/enzimología , Metabolismo Energético , Sulfuros/metabolismo , Azufre/metabolismo , Proteínas Arqueales/química , Cristalografía por Rayos X , Cisteína/química , Cisteína/metabolismo , Oxidación-Reducción , Proteínas/metabolismo , Sulfatos/metabolismo , Sulfuros/química , Sulfitos/metabolismo
13.
Immunobiology ; 218(8): 1104-12, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23583008

RESUMEN

In the present study, we analyzed the role of purinergic P2X7 receptor in Mycobacterium tuberculosis infection and host interaction mechanisms in vitro and in vivo. For experimental procedures, a macrophage murine cell line RAW 264.7, and male Swiss, wild-type C57BL/6 and P2X7 receptor knockout (P2X7R−/−) mice were used throughout this study. We have demonstrated that treatment of RAW 264.7 cells with ATP (3 and 5 mM) resulted in a statistically significant reduction of M. tuberculosis-colony-forming units. The purinergic P2X7 receptor expression was found significantly augmented in the lungs of mice infected with M. tuberculosis H37Rv. Infected wild-type mice showed a marked increase in the spleen weight, in comparison to non-infected animals. Furthermore, M. tuberculosis-infected P2X7R−/− mice showed an increase of M. tuberculosis burden in lung tissue, when compared to infected wild-type mice. In P2X7R−/− spleens, we observed a significant decrease in the populations of Treg (CD4+Foxp3+), T cells (CD4+, CD8+CD25+ and CD4+CD25+), dendritic cells (CD11c+) and B220+ cells. However, a significant increase in CD11b+ cells was observed in P2X7R−/− mice, when compared to wild-type animals. In the lungs, P2X7R−/− M. tuberculosisinfected mice exhibited pulmonary infiltrates containing an increase of Treg cells (CD4+Foxp3+), T cells (CD4+ and CD8+) and a decrease in the B220+ cells, when compared with wild-type M. tuberculosis-infected mice. The findings observed in the present study provide novel evidence on the role of P2X7 receptors in the pathogenesis of tuberculosis.


Asunto(s)
Macrófagos/inmunología , Mycobacterium tuberculosis/inmunología , Receptores Purinérgicos P2X7/inmunología , Tuberculosis/inmunología , Animales , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Línea Celular , Células Dendríticas/inmunología , Interacciones Huésped-Patógeno/inmunología , Pulmón/metabolismo , Pulmón/microbiología , Recuento de Linfocitos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Receptores Purinérgicos P2X7/genética , Tuberculosis/microbiología
14.
Naunyn Schmiedebergs Arch Pharmacol ; 384(3): 265-75, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21789632

RESUMEN

The effects of Phyllanthus niruri hydroalcoholic extract and the isolated compounds quercetin, rutin, and gallic acid were examined in the mouse model of cyclophosphamide (CYP)-induced hemorrhagic cystitis (HC). HC was induced by a single CYP injection (300 mg/kg, IP), and the animals were evaluated 4 and 6 h after. Some animals were orally treated with the reference compound 2-mercaptoethane sodium sulfonate (Mesna) 80 mg/kg (30 min before CYP) and 160 mg/kg (2 h after CYP). Other groups were treated with P. niruri extract (30 and 50 mg/kg), or quercetin, rutin, and gallic acid (10 and 20 mg/kg), given orally, at the same intervals described for Mesna. P. niruri extract and its active components produced a significant attenuation of the nociception, edema, and hemorrhage evoked by CYP, which was similar to that seen for Mesna. Gallic acid and rutin displayed greater anti-inflammatory effects, whereas quercetin presented superior antinociceptive activities. Noteworthy is that P. niruri extract and compounds significantly reduced CYP-induced liver lipid peroxidation. Our results shed new light on the beneficial effects of P. niruri extract and its active compounds in attenuating the collateral effects elicited by the chemotherapeutic agent CYP.


Asunto(s)
Antiinflamatorios/uso terapéutico , Ciclofosfamida/toxicidad , Cistitis/tratamiento farmacológico , Hemorragia/tratamiento farmacológico , Phyllanthus/química , Extractos Vegetales/uso terapéutico , Vejiga Urinaria/efectos de los fármacos , Animales , Antiinflamatorios/aislamiento & purificación , Cistitis/inducido químicamente , Ácido Gálico/aislamiento & purificación , Ácido Gálico/uso terapéutico , Hemorragia/inducido químicamente , Peroxidación de Lípido/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones , Estructura Molecular , Estrés Oxidativo/efectos de los fármacos , Dolor Pélvico/tratamiento farmacológico , Dolor Pélvico/etiología , Extractos Vegetales/aislamiento & purificación , Quercetina/aislamiento & purificación , Quercetina/uso terapéutico , Rutina/aislamiento & purificación , Rutina/uso terapéutico , Vejiga Urinaria/metabolismo , Vejiga Urinaria/patología
15.
Naunyn Schmiedebergs Arch Pharmacol ; 382(5-6): 399-407, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20809237

RESUMEN

Hemorrhagic cystitis (HC) is a common side effect observed in patients under chemotherapy with cyclophosphamide (CYP). The urotoxic side effects of CYP are attributed to the metabolic compound acrolein, and can be partially prevented by the uroprotector agent 2-mercaptoethene sulfate (Mesna). The present study analyzed the anti-inflammatory and the antinociceptive effects of compounds MV8608 and MV8612 obtained from Mandevilla velutina in the rat model of CYP-induced HC. Male Wistar rats were used (six to eight per group, 220-250 g). HC was induced by a single administration of CYP (100 mg/kg, ip). Three behavioral parameters--breathing rate, closing of the eyes, and specific posture--were used as nociception indexes, and scored at different time intervals (15-180 min) after cystitis induction. As inflammatory parameters, hemorrhage presence, edema formation, and bladder weight were determined at 24 h after CYP administration. The neutrophil migration was assessed by means of myeloperoxidase (MPO activity), 4 h after cystitis induction. As expected, Mesna treatment was able to reduce in a significant manner all the inflammatory and the nociceptive parameters induced by CYP. Of note, the administration of MV8608 significantly inhibited the hemorrhage formation and the neutrophil recruitment, while the MV8612 treatment markedly reduced the bladder weight, without interfering with neutrophil influx. Interestingly, the treatment with either MV8608 or MV8612 markedly reduced the nociceptive responses. The present results clearly indicate that MV8608 and MV8612 might represent important alternatives to prevent side effects, especially the nociception, following chemotherapy with CYP.


Asunto(s)
Antiinflamatorios/uso terapéutico , Antineoplásicos Alquilantes/efectos adversos , Apocynaceae/química , Ciclofosfamida/efectos adversos , Cistitis/prevención & control , Glicósidos/uso terapéutico , Hemorragia/prevención & control , Esteroides/uso terapéutico , Animales , Antiinflamatorios/farmacología , Cistitis/inducido químicamente , Cistitis/patología , Modelos Animales de Enfermedad , Glicósidos/farmacología , Hemorragia/inducido químicamente , Hemorragia/patología , Masculino , Mesna/uso terapéutico , Tamaño de los Órganos/efectos de los fármacos , Dimensión del Dolor , Peroxidasa/metabolismo , Sustancias Protectoras/uso terapéutico , Ratas , Ratas Wistar , Esteroides/farmacología , Vejiga Urinaria/efectos de los fármacos , Vejiga Urinaria/enzimología , Vejiga Urinaria/patología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda